These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 5030953)

  • 1. Serial transplantation of methylcholanthrene-treated mammary nodule outgrowth line D1.
    Medina D
    J Natl Cancer Inst; 1972 May; 48(5):1363-70. PubMed ID: 5030953
    [No Abstract]   [Full Text] [Related]  

  • 2. Serial transplantation of urethan-treated mammary nodule outgrowth line D1.
    Medina D
    J Natl Cancer Inst; 1972 May; 48(5):1371-5. PubMed ID: 4337908
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of various oncogenic agents on tumor-producing capabilities of series D BALB-c mammary nodule outgrowth lines.
    Medina D; DeOme KB
    J Natl Cancer Inst; 1970 Aug; 45(2):353-63. PubMed ID: 4324612
    [No Abstract]   [Full Text] [Related]  

  • 4. Response of hyperplastic alveolar nodule outgrowth-line D1 to mammary tumor virus, nodule-inducing virus, and prolonged hormonal stimulation acting singly and in combination.
    Medina D; DeOme KB
    J Natl Cancer Inst; 1969 Feb; 42(2):303-10. PubMed ID: 4303882
    [No Abstract]   [Full Text] [Related]  

  • 5. An electron microscopic study of spontaneous and experimentally induced leukemia in ICRC mice.
    Hiraki S; Ranadive KJ; Demochowski L
    Cancer Res; 1974 Mar; 34(3):474-83. PubMed ID: 4359878
    [No Abstract]   [Full Text] [Related]  

  • 6. Recovery of transformed nodule and ductal mammary cells from carcinogen-treated C57BL mice.
    Guzman RC; Osborn RC; DeOme KB
    Cancer Res; 1981 May; 41(5):1808-11. PubMed ID: 6783300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pituitary role in the growth of metastasizing MRMT-1 mammary carcinoma in rats.
    Harada Y
    Cancer Res; 1976 Jan; 36(1):18-22. PubMed ID: 1247997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial transplantation of carcinogen-treated mammary nodule outgrowths. 3. Dissociation of carcinogen-induced cell variants by dose and chemical structure of carcinogen.
    Medina D
    J Natl Cancer Inst; 1973 Jun; 50(6):1555-9. PubMed ID: 4717566
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined effects of 3-methylcholanthrene, mammary tumor virus, nodule-inducing virus, and prolonged hormonal stimulation on the tumor-producing capabilities of the nodule outgrowth line D1.
    Medina D; Faulkin LJ; DeOme KB
    J Natl Cancer Inst; 1970 Jan; 44(1):159-65. PubMed ID: 11515027
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuraminidase treated cells and their role in cancer immunotherapy.
    Simmons RL; Rios A
    Birth Defects Orig Artic Ser; 1973 Mar; 9(2):223-8. PubMed ID: 4611534
    [No Abstract]   [Full Text] [Related]  

  • 11. Susceptibility of mammary-tumor-virus-free BALB-c mouse mammary nodule outgrowth cells in DNA synthesis to 3-methylcholanthrene tumorigenesis.
    Adamson R; Banerjee MR; Medina D
    J Natl Cancer Inst; 1971 Apr; 46(4):899-907. PubMed ID: 5573774
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of hormone stimulation, dose, and time of administration of carcinogen on carcinogen-induced mammary tumors from preneoplastic nodule outgrowths.
    Medina D
    J Natl Cancer Inst; 1971 Apr; 46(4):909-16. PubMed ID: 5573775
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative immunotherapeutic effect of concanavalin A and neuraminidase-treated cancer cells.
    Simmons RL; Rios A
    Transplant Proc; 1975 Jun; 7(2):247-51. PubMed ID: 1129845
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of mammary tumorigenesis by ergot alkaloids and promotion of mammary tumorigenesis by pituitary isografts in adreno-ovariectomized mice.
    Yanai R; Nagasawa H
    J Natl Cancer Inst; 1972 Mar; 48(3):715-9. PubMed ID: 5058970
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of dietary phenylalanine deficiency on the mammary tumor virus activity in C3H mice.
    Hui YH; DeOme KB; Briggs GM
    Cancer Res; 1972 Oct; 32(10):2086-8. PubMed ID: 4343007
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunologic properties of methylcholanthrene-induced sarcomas of neonatally thymectomized mice.
    Nomoto K; Takeya K
    J Natl Cancer Inst; 1969 Mar; 42(3):445-53. PubMed ID: 5779635
    [No Abstract]   [Full Text] [Related]  

  • 17. [Oncogenic action of methylcholanthrene per os associated with pituitary graft in XVII/G mice].
    RUDALI G
    Acta Unio Int Contra Cancrum; 1962; 18():190-3. PubMed ID: 14495006
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunosuppression by antilymphocyte serum and its effect on tumors indduced by 3-methylcholanthrene in mice.
    Wagner JL; Haughton G
    J Natl Cancer Inst; 1971 Jan; 46(1):1-10. PubMed ID: 5546191
    [No Abstract]   [Full Text] [Related]  

  • 19. Leukemoid reaction in BALB-c mice bearing transplanted tumors.
    Kodama T; Sendo F; Kobayashi H
    Cancer Res; 1974 Jan; 34(1):176-80. PubMed ID: 4809456
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of multiple injections of allogeneic spleen cells on methylcholanthrene carcinogenesis in the mouse.
    Oth D; Liegey A
    Biomedicine; 1975 Feb; 23(1):17-9. PubMed ID: 1182018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.